These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 362172)

  • 21. Time-blind evaluation of psychopathology in drug research.
    Bobon DP
    Acta Psychiatr Belg; 1978; 78(4):635-45. PubMed ID: 362829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interactions between various psychopharmaceuticals].
    Eben A
    MMW Fortschr Med; 2006 Nov; 148(46):36-8. PubMed ID: 17615786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacology. The medication merry-go-round.
    Brown K
    Science; 2003 Mar; 299(5613):1646-9. PubMed ID: 12637713
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prescription of psychopharmaceuticals for children illustrated by review of prescriptions].
    Claësson BH; Zlotnik G
    Ugeskr Laeger; 1976 Dec; 138(51):3287-91. PubMed ID: 996971
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parenteral psychopharmaceuticals for agitated patients].
    Fruensgaard K
    Ugeskr Laeger; 1979 Jul; 141(28):1927-9. PubMed ID: 473416
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
    Näslund I
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of psychopharmaceuticals--should serum concentration be checked?].
    Andersen S; Refsum H; Tanum L
    Tidsskr Nor Laegeforen; 2004 Sep; 124(18):2362-4. PubMed ID: 15467801
    [No Abstract]   [Full Text] [Related]  

  • 28. [Child psychiatry and treatment with psychopharmaceuticals].
    Lund MA
    Ugeskr Laeger; 1976 Dec; 138(51):3285-6. PubMed ID: 996970
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psychopharmaceuticals in pediatric practice].
    Heimann G
    Monatsschr Kinderheilkd; 1984 Jun; 132(6):453-7. PubMed ID: 6147750
    [No Abstract]   [Full Text] [Related]  

  • 30. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?].
    Kasper S; Lentner S
    Neuropsychiatr; 2008; 22(4):221-2. PubMed ID: 19080992
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical relevance of the bioavailability/bioequivalence controversy.
    Gottschalk LA
    J Clin Psychiatry; 1986 Sep; 47 Suppl():3-5. PubMed ID: 3528133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and clinical assessment issues in the development and therapeutic evaluation of psychopharmacologic agents.
    Robinson DS; Roberts DL; Copp JE; Schwiderski U
    Psychopharmacol Bull; 1989; 25(1):9-15. PubMed ID: 2672074
    [No Abstract]   [Full Text] [Related]  

  • 33. A brief history of the new clinical drug evaluation unit meeting. How it began.
    Prien RF
    Psychopharmacol Bull; 1995; 31(1):3-5. PubMed ID: 7675986
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pindolol: a new psychotropic drug].
    Auriol B; Pinar N; Bord M
    Encephale; 1973; 62(5):427-41. PubMed ID: 4603738
    [No Abstract]   [Full Text] [Related]  

  • 35. [Psychotropic drugs in childhood and adolescence. Value and indications for pharmacotherapy of psychiatric disorders].
    Elliger T; Trott GE; Nissen G
    Fortschr Med; 1989 Apr; 107(12):263-5. PubMed ID: 2659477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychopharmaceuticals in general practice from the neurological and psychiatric viewpoint].
    Wieck HH; Zenglein R
    Z Allgemeinmed; 1975 Mar; 51(9):418-25. PubMed ID: 1163064
    [No Abstract]   [Full Text] [Related]  

  • 37. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H; Müller-Oerlinghausen B
    Arzneimittelforschung; 1974 Jul; 24(7):976-80. PubMed ID: 4603668
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapist compliance or phase IV necessities.
    Linden M
    Pharmacopsychiatry; 1984 Sep; 17(5):139. PubMed ID: 6494240
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interactions between psychopharmaceuticals and other drugs].
    Markus W
    MMW Fortschr Med; 2006 Nov; 148(46):31-5. PubMed ID: 17615785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychopharmaceuticals in the treatment of disturbed behavior in epilepsy].
    Jorgić S; Pauković M
    Neurologija; 1982; 30(1-4):91-5. PubMed ID: 7187787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.